CD36 and acute myeloid leukemia: Moreover, AML cases in the CD36-high group were enriched with KMT2A (11q23) or t(9;22) abnormalities, while cases in the CD36-low group showed a higher frequency of favorable cytogenetic abnormalities, such as t(15;17) and t(8;21).32